Jump Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jump Trading’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-20	Closed	-$2K	–	1090
2014 Q3	$2K	Buy	+20	New	+$2.78K	﹤0.01%	1164

Other funds holding MDGL

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jump Trading's MDGL Position: Q4 2014 in Review

Jump Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2014, closing a stake of 20 shares — an estimated $2K sold.

Jump Trading first reported a position in MDGL in Q3 2014 and held it in 1 quarter. The position peaked at $2K in Q3 2014. 84 funds tracked by Wall St. Rank hold MDGL as of Q4 2014.

Jump Trading reported no remaining Madrigal Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Jump Trading sold 20 Madrigal Pharmaceuticals shares in Q4 2014, an estimated $2K.
Jump Trading first reported a position in Madrigal Pharmaceuticals in Q3 2014 and held it in 1 quarter.
Jump Trading's Madrigal Pharmaceuticals position peaked at $2K in Q3 2014.
84 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2014.

Based on Jump Trading's 13F filing for Q4 2014, filed 17 Feb 2015.